2-(DODECYLOXY)ETHANOL
Product Information
Molecular Formula
C14H30O2
Molecular Weight
230.39
Description
Laureth 4 is a polymer.
Synonyms
2-(Dodecyloxy)ethanol
IUPAC Name
2-dodecoxyethanol
SMILES
CCCCCCCCCCCCOCCO
InChI
InChI=1S/C14H30O2/c1-2-3-4-5-6-7-8-9-10-11-13-16-14-12-15/h15H,2-14H2,1H3
InChI Key
SFNALCNOMXIBKG-UHFFFAOYSA-N
Boiling Point
133 °C/2 mmHg
Melting Point
20 °C
Flash Point
75 °C
Purity
>96.0%(GC)
Density
0.873
Appearance
White or Colorless to Almost white or Almost colorless powder to lump to clear liquid
Refractive Index
n20/D 1.446
Stability
Stable.
Computed Properties
XLogP3
5.1
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
13
Exact Mass
230.224580195 g/mol
Monoisotopic Mass
230.224580195 g/mol
Topological Polar Surface Area
29.5Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
115
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021122382-A1 | Aqueous composition comprising a cationic polymer, an anionic polymer, an anionic surfactant comprising at least one cationic counterion, a fatty phase and a pigment | 2019-12-16 |
| WO-2021122383-A1 | Aqueous composition comprising a cationic cellulosic polymer, an anionic surfactant comprising at least one cationic counterion, a fatty phase and a pigment | 2019-12-16 |
| WO-2021117837-A1 | Ionic-group-containing microballoon and production method therefor | 2019-12-11 |
| US-2021169903-A1 | Pharmaceutical compositions and methods | 2019-12-09 |
| WO-2021119096-A1 | Pharmaceutical compositions and methods | 2019-12-09 |
| WO-2021110733-A1 | A cosmetic composition and the use thereof and a method for improving sensory characteristics | 2019-12-04 |
| WO-2021106822-A1 | Method for controlling branched fatty acid metabolism | 2019-11-25 |
| WO-2021099114-A1 | One component (1k) anaerobic curable composition | 2019-11-18 |
| WO-2021095339-A1 | Nonaqueous inkjet ink and printed material of same | 2019-11-14 |
| WO-2021085215-A1 | Polycarbodiimide compound, aqueous resin composition and food packaging container | 2019-10-31 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 22531012 | 2012-09-01 | Low concentration detergent sclerosants induce platelet activation but inhibit aggregation due to suppression of GPIIb/IIIa activation in vitro | Thrombosis research |
| 22686430 | 2012-09-01 | Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study | Journal of plastic surgery and hand surgery |
| 22620717 | 2012-08-01 | Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] |
| 22627969 | 2012-08-01 | Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein | The British journal of surgery |
| 22875366 | 2012-08-01 | Management of chronic Achilles tendinopathy | Drug and therapeutics bulletin |
| 22268976 | 2012-07-01 | Hand rejuvenation: a review and our experience | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] |
| 22546640 | 2012-07-01 | Extravascular injection of sclerotic agents does not affect vessels in the rat: experimental implications for percutaneous sclerotherapy of arteriovenous malformations | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery |
| 22733913 | 2012-07-01 | Balloon-occluded retrograde transvenous obliteration of gastric varices: use of CT-guided foam sclerotherapy to optimize technique | AJR. American journal of roentgenology |
| 22825857 | 2012-07-01 | Sclerotherapy in an undetected pregnancy - a catastrophe? | VASA. Zeitschrift fur Gefasskrankheiten |
| 22045827 | 2012-06-01 | Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study) | Phlebology |
